Computer-Delivered PFI for Anxiety Sensitivity/Alcohol Intervention for Hazardous Drinkers With Elevated Anxiety Sensitivity
NCT03917875 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 130
Last updated 2020-02-25
Summary
Hazardous alcohol consumption is one of the leading causes of preventable deaths in the United States. Further, it is highly comorbid with anxiety and depressive symptoms and disorders; hazardous alcohol use is associated with increased anxiety/depression. Indeed, 'affectively-vulnerable hazardous drinkers' (i.e., drinkers with elevated negative mood states or psychopathology) are 'at risk' for higher drinking rates, more problematic drinking, worsened mental health, and greater disability. Specialty care options are needed to address the unique 'affective needs' of hazardous drinkers. One promising intervention approach is to employ personalized feedback interventions (PFI). These interventions are brief, efficient, and have been shown to be effective in a number of settings and across an array of populations. However, PFIs have not been evaluated among affectively vulnerable hazardous drinkers.
In order to address the heterogeneity of negative mood states and disorders among hazardous drinkers, there is a need to theoretically orient the intervention approach on underlying transdiagnostic processes that underpin affective psychopathology. Anxiety sensitivity (AS), the tendency to fear anxiety-related sensations, is a core transdiagnostic vulnerability factor underlying the etiology and maintenance of anxiety disorders, other emotional disorders, and hazardous drinking. AS is malleable in response to psychosocial interventions, making it a prime risk factor to target in prevention/intervention programs, including PFI approaches. Integrated treatments that address hazardous drinking via AS are nonexistant. As most hazardous drinkers typically do not access treatment because of such barriers as cost, time commitments, stigma, and logistics (e.g., travel, scheduling appointments), there is a need to develop an accessible, brief, integrated tool to explicitly address the drinking-affective vulnerability comorbidity via AS. To address this public health gap, the current proposal seeks to employ a computer-delivered integrated PFI that directly addresses hazardous drinking-AS in a personalized manner. Hazardous drinkers with elevated AS will be randomly assigned to receive one session of PFI or attention information control with follow-up assessments at one week and one month post-intervention. The PFI will focus on targeted feedback about drinking behaviors, AS, and adaptive coping strategies.
Conditions
- Alcohol Drinking
- Anxiety
- Coping Behavior
Interventions
- BEHAVIORAL
-
Personalized feedback intervention
The novel integrated PFI will be developed and modeled from past PFIs targeting hazardous drinking. Participants will view feedback on the computer screen. The computer program/algorithm will determine the proper normative feedback to participants.
Sponsors & Collaborators
-
University of Houston
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2016-09-01
- Primary Completion
- 2019-12-31
- Completion
- 2019-12-31
Countries
- United States
Study Locations
More Related Trials
-
Amplification of Positivity for Alcohol Use
NCT06030154 ·Status: RECRUITING ·Phase: NA
-
Frontal-Striatal Reward Circuit Neuromodulation and Alcohol Self-Administration
NCT04971681 ·Status: TERMINATED ·Phase: NA
-
Development of an Anxiety Sensitivity-Based Intervention for Substance Use and Anxiety Comorbidity
NCT02667015 ·Status: COMPLETED ·Phase: PHASE2
-
Remote Alcohol Monitoring and Episodic Thinking
NCT03340051 ·Status: COMPLETED ·Phase: NA
-
Combination of Naltrexone and Baclofen for Alcohol Dependence:A Pilot Study.
NCT00614328 ·Status: COMPLETED ·Phase: PHASE1
-
Mindfulness-Based Relapse Prevention for Alcohol Use Disorders in Remission
NCT02147483 ·Status: COMPLETED ·Phase: NA
-
Collaborative Care for Alcohol Use Disorders in the Patient-centered Medical Home
NCT02885311 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Synergistic Effects of Anxiety and Alcohol Use Among Latinos and Its Sociocultural Mechanisms
NCT03807817 ·Status: COMPLETED ·Phase: NA
-
Corticotropin-Releasing Hormone Receptor 1 (CRH1) Antagonism in Anxious Alcoholics^
NCT01227980 ·Status: COMPLETED ·Phase: PHASE2
-
Outpatient Psychotherapeutic Treatment for Alcohol Dependent Individuals With Comorbid Psychiatric Disorders
NCT02141789 ·Status: COMPLETED ·Phase: NA
-
Targeted Naltrexone for Problem Drinkers
NCT00369408 ·Status: COMPLETED ·Phase: PHASE4
-
Developing Functional Connectivity-Guided TMS for Alcohol Use Disorder
NCT06415721 ·Status: RECRUITING ·Phase: NA
-
Expanding Reach of Evidence-based Psychotherapy for Veterans With Co-occurring Anxiety and Substance Use Disorders.
NCT05372185 ·Status: COMPLETED ·Phase: NA
-
Naltrexone, Craving, and Drinking
NCT00006203 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluating Neuromodulation Technologies in Early Recovery
NCT01993277 ·Status: UNKNOWN ·Phase: NA
-
Individualized Assessment and Treatment for Alcoholism II
NCT03233802 ·Status: COMPLETED ·Phase: NA
-
Oxytocin Treatment of Alcohol Dependence
NCT02251912 ·Status: COMPLETED ·Phase: PHASE2
-
Medication and Counseling for Controlled Drinking
NCT01115894 ·Status: UNKNOWN ·Phase: PHASE3
-
PT150 Drug for Use in Alcohol Use Disorder
NCT06712602 ·Status: RECRUITING ·Phase: PHASE1
-
Strengths-based Linkage to Alcohol Care (SLAC) for Hazardous Drinkers in Primary Care
NCT05023317 ·Status: COMPLETED ·Phase: PHASE1
-
Environment and Alcohol: A Pilot Study
NCT06860607 ·Status: RECRUITING ·Phase: PHASE1
-
Reducing Alcohol Use in Depressed Patients
NCT00183079 ·Status: COMPLETED ·Phase: PHASE2
-
Oxytocin Treatment of Alcohol Dependence
NCT02275611 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of High Dose Baclofen for Alcohol Dependence
NCT01980706 ·Status: COMPLETED ·Phase: PHASE2
-
Pharmacological Treatment for Alcoholism
NCT00382642 ·Status: COMPLETED ·Phase: PHASE3